The pretreatment of lymphoma cells with DAPT (5 μM) with or without NSC23766 (Rac-specific small-molecule inhibitor) for 24 h showed a significant decrease of the lymphoma stem cell population and an increased sensitivity to doxorubicin [35]. Here, AKT1 is linked to lymphoma.